Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1B | P49286 | 11/20 | 0.50 |
| ▸ | MTNR1A | P48039 | 10/20 | 0.50 |
| ▸ | F2R | P25116 | 2/20 | 0.43 |
| ▸ | HTR2A | P28223 | 3/20 | 0.42 |
| ▸ | HTR2C | P28335 | 3/20 | 0.42 |
| ▸ | HTR2B | P41595 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8097498 | 1.00 | MTNR1B (0.50) | MTNR1BMTNR1AF2RHTR2AHTR2C | |
| SCHEMBL8097743 | 0.88 | MTNR1B (0.51) | MTNR1BMTNR1AHTR2AHTR2CHTR2B | |
| SCHEMBL8097747 | 0.88 | MTNR1B (0.51) | MTNR1BMTNR1AHTR2AHTR2CHTR2B | |
| SCHEMBL8096217 | 0.86 | MTNR1B (0.49) | MTNR1BMTNR1AHTR2AHTR2CHTR2B | |
| SCHEMBL9019896 | 0.86 | MTNR1B (0.49) | MTNR1BMTNR1AHTR2AHTR2CHTR2B | |
| SCHEMBL8088398 | 0.84 | MTNR1A (0.53) | MTNR1BMTNR1A | |
| SCHEMBL8088400 | 0.84 | MTNR1A (0.53) | MTNR1BMTNR1A | |
| SCHEMBL8097079 | 0.81 | MTNR1A (0.45) | MTNR1BMTNR1AHTR2AHTR2CHTR2B | |
| SCHEMBL8097076 | 0.81 | MTNR1A (0.45) | MTNR1BMTNR1AHTR2AHTR2CHTR2B | |
| SCHEMBL8088845 | 0.78 | MTNR1B (0.51) | MTNR1BMTNR1AHTR2AHTR2CHTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0747346-B1 | N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics | BRISTOL MYERS SQUIBB CO (US) | 2000-02-16 | — | — | EP | claimed |
| EP-0747346-A2 | N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-12-11 | — | — | EP | claimed |
| EP-0747346-B1 | N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics | BRISTOL MYERS SQUIBB CO (US) | 2000-02-16 | — | — | EP | disclosed |
| EP-0747346-A2 | N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-12-11 | — | — | EP | disclosed |